Published Ahead of Print

February 17, 2022

Open Access
⁶⁸Ga-DOTA-NT-20.3 Neurotensin receptor 1 positron emission tomography imaging as a surrogate for neuroendocrine differentiation of prostate cancer
Wen Yu Wu, Fei Yu, Peng Jun Zhang, Ting Bu, Jing Jing Fu, Shu Yue Ai, Qin Qin You, Liang Shi, Guo Qiang Shao, Feng Wang, Marina Hodolic and Hong Qian Guo

Journal of Nuclear Medicine February 17, 2022, jnumed.121.263132; DOI: https://doi.org/10.2967/jnumed.121.263132
Open Access
Molecular imaging findings on acute and long-term effects of COVID-19 on the brain: A systematic review
Philipp T Meyer, Sabine Hellwig, Ganna Blazhenets and Jonas A Hosp

Journal of Nuclear Medicine February 17, 2022, jnumed.121.263085; DOI: https://doi.org/10.2967/jnumed.121.263085
You have access
Radium 223 induces transient functional bone marrow toxicity
Maria Parlani, Francesco Boccalatte, Anna Yeaton, Feng Wang, Jianhua Zhang, Iannis Aifantis and Eleonora Dondossola

Journal of Nuclear Medicine February 17, 2022, jnumed.121.263310; DOI: https://doi.org/10.2967/jnumed.121.263310
You have access
TRACKING INNATE IMMUNE ACTIVATION IN A MOUSE MODEL OF PARKINSON’S DISEASE USING TREM1 AND TSPO PET TRACERS
Katherine Lindsay Lucot, Marc Yendall Stevens, T. Adam Bonham, E. Carmen Azevedo, Aisling M. Chaney, Ebony Danielle Webber, Poorva Jain, Jessica Lee Klockow, Isaac Mackenzie Jackson, Mackenzie Leigh Carlson, Edward E. Graves, Thomas Jude Montine and Michelle Louise James

Journal of Nuclear Medicine February 17, 2022, jnumed.121.263039; DOI: https://doi.org/10.2967/jnumed.121.263039
Open Access
mCRPC patients receiving ²²⁵Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis
Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, Ismaheel Lawal, Otto Knoesen, Johncy Mahapane, Cindy Davis, Amanda Mdlophane, Alex Maes, Kgomotso Mokoala, Kgomotso Mathabe, Christophe Van de Wiele and Alfred Morgenstern

Journal of Nuclear Medicine February 17, 2022, jnumed.121.263618; DOI: https://doi.org/10.2967/jnumed.121.263618

February 10, 2022

You have access
Prognostic value of Urokinase-type Plasminogen Activator Receptor (uPAR)-PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with ¹⁸F-FDG-PET/CT: A single-center prospective study
Louise Madeleine Risør, Malene Martini Clausen, Zaza Ujmajuridze, Mohammed Farhadi, Kim Francis Andersen, Annika Loft, Jeppe Friborg and Andreas Kjaer

Journal of Nuclear Medicine February 10, 2022, jnumed.121.262866; DOI: https://doi.org/10.2967/jnumed.121.262866
You have access
Alzheimer’s disease – standard of diagnosis, treatment, care, and prevention
Stefan Teipel, Deb Gustafson, Rik Ossenkoppele, Oskar Hansson, Claudio Babiloni, Michael Wagner, Steffie Riedel-Heller, Ingo Kilimann and Yi Tang

Journal of Nuclear Medicine February 10, 2022, jnumed.121.262239; DOI: https://doi.org/10.2967/jnumed.121.262239
Open Access
MIRD Pamphlet No. 27: MIRDcell V3, a revised software tool for multicellular dosimetry and bioeffect modeling
Sumudu Katugampola, Jianchao Wang, Alex Rosen and Roger W. Howell

Journal of Nuclear Medicine February 10, 2022, jnumed.121.263253; DOI: https://doi.org/10.2967/jnumed.121.263253

February 3, 2022

You have access
Assessing reactive astrogliosis with ¹⁸F-SMBT-1 across the Alzheimer’s disease spectrum
Victor L Villemagne, Ryuichi Harada, Vincent Dore, Shozo Furumoto, Rachel Mulligan, Yukitsuka Kudo, Samantha Burnham, Natasha Krishnadas, Pierrick Bourgeat, Ying Xia, Simon Laws, Svetlana Bozinovski, Kun Huang, Milos D Ikonomovic, Jurgen Fripp, Kazuhiko Yanai, Nobuyuki Okamura and Christopher C Rowe

Journal of Nuclear Medicine February 3, 2022, jnumed.121.263255; DOI: https://doi.org/10.2967/jnumed.121.263255
You have access
¹⁸F-FDG Fetal Dosimetry Calculated with PET/MRI
Paolo Zanotti-Fregonara, Tatsuya Ishiguro, Kosuke Yoshihara, Shiro Ishii and Takayuki Enomoto

Journal of Nuclear Medicine February 3, 2022, jnumed.121.263561; DOI: https://doi.org/10.2967/jnumed.121.263561
You have access
¹⁸F-PFPN PET: a new and attractive imaging modality for patients with malignant melanoma
Xiao Zhang, Mengting Li, Yongkang Gai, Jing Chen, Juan Tao, Liu Yang, Fan Hu, Wenyu Song, Tzu-Chen Yen and Xiaoli Lan

Journal of Nuclear Medicine February 3, 2022, jnumed.121.263179; DOI: https://doi.org/10.2967/jnumed.121.263179
Open Access
Short-term colony stimulating factor-1 receptor inhibition-induced repopulation after stroke assessed by longitudinal ¹⁸F-DPA-714 PET imaging
Cristina Barca, Amanda J Kiliaan, Lydia Wachsmuth, Claudia Foray, Sven Hermann, Cornelius Faber, Michael Schaefers, Maximilian Wiesmann, Bastian Zinnhardt and Andreas H Jacobs

Journal of Nuclear Medicine February 3, 2022, jnumed.121.263004; DOI: https://doi.org/10.2967/jnumed.121.263004
Open Access
Interrogating glioma-associated microglia/macrophage dynamics under CSF-1R therapy with multi-tracer in vivo PET/MR imaging
Claudia Foray, Cristina Barca, Alexandra Winkeler, Stefan Wagner, Sven Hermann, Michael Schaefers, Oliver Martin Grauer, Bastian Zinnhardt and Andreas H Jacobs

Journal of Nuclear Medicine February 3, 2022, jnumed.121.263318; DOI: https://doi.org/10.2967/jnumed.121.263318
Open Access
Analysis of short term and stable DNA damage in patients with differentiated thyroid cancer treated with ¹³¹I in hypothyroidism or with rhTSH for remnant ablation
Alberto Signore, Giuseppe Campagna, Jessica Marinaccio, Marco de Vitis, Chiara Lauri, Francesco Berardinelli, Anna Tofani, Marco Chianelli, Marina Borro, Giovanna Gentile, Maurizio Simmaco, Francesco Colombini, Anna Giovanetti and Antonella Sgura

Journal of Nuclear Medicine February 3, 2022, jnumed.121.263442; DOI: https://doi.org/10.2967/jnumed.121.263442
You have access
First-in-human evaluation of ¹⁸F-SMBT-1, a novel ¹⁸F-labeled MAO-B PET tracer for imaging reactive astrogliosis
Victor L Villemagne, Ryuichi Harada, Vincent Dore, Shozo Furumoto, Rachel Mulligan, Yukitsuka Kudo, Samantha Burnham, Natasha Krishnadas, Svetlana Bozinovski, Kun Huang, Brian J Lopresti, Kazuhiko Yanai, Christopher C Rowe and Nobuyuki Okamura

Journal of Nuclear Medicine February 3, 2022, jnumed.121.263254; DOI: https://doi.org/10.2967/jnumed.121.263254

January 27, 2022

You have access
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study
Jean-Baptiste Alberge, Francoise Kraeber-Bodere, Bastien Jamet, Cyrille Touzeau, Helene Caillon, Soraya Wuilleme, Marie-Christine Bene, Tobias Kampfenkel, Pieter Sonneveld, Mark Van Duin, Herve Avet-Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet-Milin, Michel Cherel, Philippe Moreau, Stephane Minvielle and Clement Bailly

Journal of Nuclear Medicine January 27, 2022, jnumed.121.262884; DOI: https://doi.org/10.2967/jnumed.121.262884
Open Access
Synthesis and Preclinical Evaluation of ¹⁷⁷Lu-labeled Radiohybrid PSMA Ligands (rhPSMAs) for Endoradiotherapy of Prostate Cancer
Alexander Wurzer, Jan-Philip Kunert, Sebastian Fischer, Veronika Felber, Roswitha Beck, Francesco De Rose, Calogero D'Alessandria, Wolfgang Andreas Weber and Hans-Jürgen Wester

Journal of Nuclear Medicine January 27, 2022, jnumed.121.263371; DOI: https://doi.org/10.2967/jnumed.121.263371
Open Access
Evaluation of Data-Driven Rigid Motion Correction in Clinical Brain PET Imaging
Matthew G Spangler-Bickell, Samuel A Hurley, Ali Pirasteh, Scott B Perlman, Timothy W Deller and Alan B McMillan

Journal of Nuclear Medicine January 27, 2022, jnumed.121.263309; DOI: https://doi.org/10.2967/jnumed.121.263309
You have access
Positron emission tomography imaging of system xc^– in immune cells for assessment of disease activity in mice and patients with inflammatory bowel disease
Minjung Seo, Yeji Kim, Byong Duk Ye, Sang Hyoung Park, Seog-Young Kim, Jin Hwa Jung, Sung Wook Hwang, Sun Young Chae, Dong Yun Lee, Sang Ju Lee, Seung Jun Oh, Jihun Kim, Ji Young Kim, Sae Jung Na, Misung Kim, Sang-Yeob Kim, Norman Koglin, Andrew W Stephens, Mi-Na Kweon and Dae Hyuk Moon

Journal of Nuclear Medicine January 27, 2022, jnumed.121.263289; DOI: https://doi.org/10.2967/jnumed.121.263289
You have access
Why We Did What We Did: PSMA-PET/CT Selection Criteria for the VISION Trial
Phillip Hsin Kuo, Taylor Benson, Richard Messmann and Michael Groaning

Journal of Nuclear Medicine January 27, 2022, jnumed.121.263638; DOI: https://doi.org/10.2967/jnumed.121.263638

January 20, 2022

You have access
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations
Sue Bunning, Christopher Ignace, Steve Mattmuller, Sally W Schwarz, Peter J H Scott, Steve Zigler and Henry F. Van Brocklin

Journal of Nuclear Medicine January 20, 2022, jnumed.121.263443; DOI: https://doi.org/10.2967/jnumed.121.263443
You have access
Prospective phase II trial of prognostication by ⁶⁸Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy
Esben Andreas Carlsen, Mathias Loft, Annika Loft, Anne Kiil Berthelsen, Seppo Wang Langer, Ulrich Knigge and Andreas Kjaer

Journal of Nuclear Medicine January 20, 2022, jnumed.121.263177; DOI: https://doi.org/10.2967/jnumed.121.263177
You have access
The change in management by ¹⁸F-DCFPyL PSMA PET scanning in patients undergoing post-prostatectomy radiotherapy, with early biochemical response outcomes.
Michael Ng, Mario Guerrieri, Lih Ming Wong, Kim Taubman, Tom Sutherland, Angela Benson, Graeme Byrne, Sam Koschel, Kelvin Yap, Grace Ong, Craig Macleod, Marcus Foo and Michael Chao

Journal of Nuclear Medicine January 20, 2022, jnumed.121.263521; DOI: https://doi.org/10.2967/jnumed.121.263521
You have access
Molecular imaging of Neuroendocrine Prostate Cancer by targeting Delta-like Ligand 3
Joshua Aaron Korsen, Teja Muralidhar Kalidindi, Samantha Khitrov, Zachary V. Samuels, Goutam Chakraborty, Julia A. Gutierrez, John T. Poirier, Charles M. Rudin, Yu Chen, Michael J. Morris, NagaVaraKishore Pillarsetty and Jason S. Lewis

Journal of Nuclear Medicine January 20, 2022, jnumed.121.263221; DOI: https://doi.org/10.2967/jnumed.121.263221

January 13, 2022

You have access
Letter to the Editor RE: Tumor sink effect in ⁶⁸Ga-PSMA-11 PET: Myth or Reality?
Bastiaan M. Prive, Steffie Peters, Maike J.M. Uijen, Marcel J.R. Janssen, Willemijn A.M. van Gemert, Michael C. Kreissl, Samer Ezziddin, Mark W. Konijnenberg and James Nagarajah

Journal of Nuclear Medicine January 13, 2022, jnumed.122.263802; DOI: https://doi.org/10.2967/jnumed.122.263802
Open Access
Substitution of L-Trp by α-methyl-L-Trp in ¹⁷⁷Lu-RM2 results in ¹⁷⁷Lu-AMTG, a high affinity GRPR ligand with improved in vivo stability
Thomas Guenther, Sandra Deiser, Veronika Felber, Roswitha Beck and Hans-Juergen Wester

Journal of Nuclear Medicine January 13, 2022, jnumed.121.263323; DOI: https://doi.org/10.2967/jnumed.121.263323
You have access
In vivo evaluation of six analogs of ¹¹C-ER176 as candidate ¹⁸F-labeled radioligands for translocator protein 18 kDa (TSPO)
Jae-Hoon Lee, Fabrice G. Simeon, Jeih-San Liow, Cheryl L. Morse, Robert L. Gladding, Jose Angel Montero Santamaria, Ioline D. Henter, Sami S. Zoghbi, Victor W. Pike and Robert B. Innis

Journal of Nuclear Medicine January 13, 2022, jnumed.121.263168; DOI: https://doi.org/10.2967/jnumed.121.263168
Open Access
SV2A PET imaging is a non-invasive marker for the detection of spinal damages in experimental models of spinal cord injury
Daniele Bertoglio, Nicolas Halloin, Stef De Lombaerde, Aleksandar Jankovski, Jeroen Verhaeghe, Charles Nicaise and Steven Staelens

Journal of Nuclear Medicine January 13, 2022, jnumed.121.263222; DOI: https://doi.org/10.2967/jnumed.121.263222
Open Access
Fluorescent molecular imaging can improve intraoperative sentinel margin detection in oral squamous cell carcinoma
Giri Krishnan, Nynke S van den Berg, Naoki Nishio, Shrey Kapoor, Jaqueline Pei, Laura Freeman, Yu-Jin Lee, Stan van Keulen, Shayan Fakurnejad, James Condon, Fred Back, Brock Martin and Eben L Rosenthal

Journal of Nuclear Medicine January 13, 2022, jnumed.121.262235; DOI: https://doi.org/10.2967/jnumed.121.262235

January 6, 2022

You have access
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in ¹⁸F-FDG PET scans of patients with classical Hodgkin lymphoma
Julia Driessen, Gerben JC Zwezerijnen, Heiko Schöder, Esther EE Drees, Marie José Kersten, Alison J Moskowitz, Craig H Moskowitz, Jakoba J Eertink, Henrica CW De Vet, Otto S Hoekstra, Joseé M Zijlstra and Ronald Boellaard

Journal of Nuclear Medicine January 6, 2022, jnumed.121.263067; DOI: https://doi.org/10.2967/jnumed.121.263067
You have access
Targeted Alpha-Emitter Therapy With ²¹²Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Human, Dose-Escalation Clinical Trial
Ebrahim S Delpassand, Izabela Tworowska, Rouzbeh Esfandiari, Julien Torgue, Jason Hurt, Afshin Shafie and Rodolfo Núñez

Journal of Nuclear Medicine January 6, 2022, jnumed.121.263230; DOI: https://doi.org/10.2967/jnumed.121.263230
You have access
Utility of ¹⁸F-rhPSMA-7.3 positron emission tomography for imaging of primary prostate cancer and pre-operative efficacy in N-staging of unfavorable intermediate to very high-risk patients validated by histopathology
Thomas Langbein, Hui Wang, Isabel Rauscher, Markus Krönke, Karina Knorr, Alexander Wurzer, Kristina Schwamborn, Tobias Maurer, Thomas Horn, Bernhard Haller, Hans-Jürgen Wester and Matthias Eiber

Journal of Nuclear Medicine January 6, 2022, jnumed.121.263440; DOI: https://doi.org/10.2967/jnumed.121.263440
You have access
SIR-Spheres activity measurements reveal systematic miscalibration
Stephen A Graves, Molly Martin, Ashok Tiwari, Michael J Merrick and John J Sunderland

Journal of Nuclear Medicine January 6, 2022, jnumed.121.262650; DOI: https://doi.org/10.2967/jnumed.121.262650

December 21, 2021

You have access
Efficient delay correction for total-body PET kinetic modeling using pulse timing methods
Elizabeth Li, Benjamin A. Spencer, Jeffrey P. Schmall, Yasser Abdelhafez, Ramsey D. Badawi, Guobao Wang and Simon R. Cherry

Journal of Nuclear Medicine December 21, 2021, jnumed.121.262968; DOI: https://doi.org/10.2967/jnumed.121.262968
You have access
The VISION Forward: Recognition and Implication of PSMA-/FDG+ mCRPC
Hossein Jadvar

Journal of Nuclear Medicine December 21, 2021, jnumed.121.263274; DOI: https://doi.org/10.2967/jnumed.121.263274
Open Access
Effects of tracer uptake time in non-small cell lung cancer ¹⁸F-FDG PET radiomics
Guilherme Domingues Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben Johannes Cornelis Zwezerijnen, Egbert F. Smit, Adrianus Johannes De Langen, Irène Buvat and Ronald Boellaard

Journal of Nuclear Medicine December 21, 2021, jnumed.121.262660; DOI: https://doi.org/10.2967/jnumed.121.262660
You have access
Optimizing immunoPET imaging of tumor PD-L1 expression: pharmacokinetics, biodistribution and dosimetric comparisons of ⁸⁹Zr-labeled anti-PD-L1 antibody formats
ALIZEE BOULEAU, HERVE NOZACH, STEVEN DUBOIS, DIMITRI KERESELIDZE, CELINE CHEVALEYRE, CHENG-I WANG, Michael John Evans, VINCENT LEBON, BERNARD MAILLERE and Charles TRUILLET

Journal of Nuclear Medicine December 21, 2021, jnumed.121.262967; DOI: https://doi.org/10.2967/jnumed.121.262967

December 16, 2021

You have access
Radiation Protection and Occupational Exposure on [⁶⁸Ga]Ga-PSMA-11 based Cerenkov Luminescence Imaging Procedures in robot assisted Prostatectomy
Pedro Fragoso Costa, Wolfgang Peter Fendler, Ken Herrmann, Patrick Sandach, Hong Grafe, Maarten Grootendorst, Lukas Puellen, Claudia Kesch, Ulrich Krafft, Jan Philipp Radtke, Stephan Philipp Tschirdewahn, Boris Hadaschik and Christopher Darr

Journal of Nuclear Medicine December 16, 2021, jnumed.121.263175; DOI: https://doi.org/10.2967/jnumed.121.263175
You have access
Comparison of ¹¹C-Pittsburgh compound-B and ¹⁸F-Flutemetamol White Matter Binding in PET
Burcu Zeydan, Christopher G Schwarz, Scott A Przybelski, Timothy G Lesnick, Walter K Kremers, Matthew L Senjem, Orhun H Kantarci, Paul H Min, Bradley J Kemp, Clifford R Jack, Kejal Kantarci and Val J Lowe

Journal of Nuclear Medicine December 16, 2021, jnumed.121.263281; DOI: https://doi.org/10.2967/jnumed.121.263281
You have access
Predictors of ¹⁸F-DCFPyL-PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
Esther Mena, Steven P. Rowe, Joanna H. Shih, Liza Lindenberg, Baris Turkbey, Aloyse Fourquet, Frank I. Lin, Stephen Adler, Philip Eclarinal, Yolanda L. McKinney, Deborah E. Citrin, William Dahut, Bradford J. Wood, Richard Chang, Elliot Levy, Maria Merino, Michael A. Gorin, Martin G. Pomper, Peter A. Pinto, Janet F. Eary, Peter L. Choyke and Kenneth J. Pienta

Journal of Nuclear Medicine December 16, 2021, jnumed.121.262347; DOI: https://doi.org/10.2967/jnumed.121.262347
You have access
Independent Prognostic Utility of ¹¹C-Pittsburgh Compound B Positron Emission Tomography in Light-Chain Cardiac Amyloidosis Patients
You-Jung Choi, Youngil Koh, Hyun-Jung Lee, In-Chang Hwang, Jun-Bean Park, Yeonyee E. Yoon, Hack-Lyoung Kim, Hyung-Kwan Kim, Yong-Jin Kim, Goo-Yeong Cho, Dae-Won Sohn, Jin-Chul Paeng and Seung-Pyo Lee

Journal of Nuclear Medicine December 16, 2021, jnumed.121.263033; DOI: https://doi.org/10.2967/jnumed.121.263033

December 9, 2021

You have access
Prostate-specific membrane antigen radioligand therapy using ¹⁷⁷Lu-PSMA I&T and ¹⁷⁷Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: comparison of safety, biodistribution and dosimetry
Christiane Schuchardt, Jingjing Zhang, Harshad R. Kulkarni, Xiaoyuan Chen, Dirk Mueller and Richard P. Baum

Journal of Nuclear Medicine December 9, 2021, jnumed.121.262713; DOI: https://doi.org/10.2967/jnumed.121.262713
You have access
Book Review: Nuclear Medicine Textbook - Methodology and Clinical Applications
Hossein Jadvar

Journal of Nuclear Medicine December 9, 2021, jnumed.121.263612; DOI: https://doi.org/10.2967/jnumed.121.263612
You have access
FDG-PET/CT-based prognostic survival model after surgery for head and neck cancer
Gwenaelle CREFF, Franck JEGOUX, Xavier Palard-Novello, Adrien Depeursinge, Ronan ABGRAL, Remi Marianowski, Jean Christophe Leclere, Thomas EUGENE, Olivier Malard, Renaud De Crevoisier, Anne Devillers and Joel Castelli

Journal of Nuclear Medicine December 9, 2021, jnumed.121.262891; DOI: https://doi.org/10.2967/jnumed.121.262891
You have access
The Will Rodgers Phenomenon and PSMA PET/CT
Nicholas C Friedman

Journal of Nuclear Medicine December 9, 2021, jnumed.121.263556; DOI: https://doi.org/10.2967/jnumed.121.263556
You have access
Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection
Jihye Kim, Ju Yeon Kim, Jeong-Hoon Lee, Dong Hyun Sinn, Moon Haeng Hur, Ji Hoon Hong, Min Kyung Park, Hee Jin Cho, Na Ryung Choi, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jin Chul Paeng, Hyo Cheol Kim, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Dongho Hyun, Jong Man Kim and Jung-Hwan Yoon

Journal of Nuclear Medicine December 9, 2021, jnumed.121.263147; DOI: https://doi.org/10.2967/jnumed.121.263147

December 2, 2021

Open Access
Use of ⁶⁴Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine (T-DM1) for Metastatic Breast Cancer: A Pilot Study
Joanne E. Mortimer, James R. Bading, Paul H Frankel, Mary Caroll, Yuan Yuan, Jinha Park, Lusine Tumyan, Nikita Gidwaney, Erasmus Kofi Poku, John E Shively and David Colcher

Journal of Nuclear Medicine December 2, 2021, jnumed.121.262940; DOI: https://doi.org/10.2967/jnumed.121.262940
You have access
Biodistribution and radiation dosimetry of intraperitoneally administered ¹²⁴I-omburtamab in patients with desmoplastic small round cell tumors
Milan Grkovski, Shakeel Modak, Pat B. Zanzonico, Jorge A. Carrasquillo, Steven M. Larson, John Laurence Humm and Neeta Pandit-Taskar

Journal of Nuclear Medicine December 2, 2021, jnumed.121.262793; DOI: https://doi.org/10.2967/jnumed.121.262793
Open Access
Absolute lymphocyte count after COVID-19 vaccination is associated with vaccine-induced hypermetabolic lymph nodes on ¹⁸F-FDG PET/CT: a focus in breast cancer care.
Romain-David Seban, Capucine Richard, Camila Nascimento-Leite, Jerome Ghidaglia, Claire Provost, Julie Gonin, Christophe Le Tourneau, Emanuela Romano, Nicolas Deleval and Laurence Champion

Journal of Nuclear Medicine December 2, 2021, jnumed.121.263082; DOI: https://doi.org/10.2967/jnumed.121.263082
You have access
Head-to-head comparison of ⁶⁸Ga-FAPI-46 and ¹⁸F-FDG PET/CT for evaluation of head and neck squamous cell carcinoma: a single-center exploratory study
Chetsadaporn Promteangtrong, Dheeratama Siripongsatian, Attapon Jantarato, Anchisa Kunawudhi, Peerapon Kiatkittikul, Sukanya Yaset, Natphimol Boonkawin and Chanisa Chotipanich

Journal of Nuclear Medicine December 2, 2021, jnumed.121.262831; DOI: https://doi.org/10.2967/jnumed.121.262831

Main menu

User menu

Search

Published Ahead of Print

February 17, 2022

February 10, 2022

February 3, 2022

January 27, 2022

January 20, 2022

January 13, 2022

January 6, 2022

December 21, 2021

December 16, 2021

December 9, 2021

December 2, 2021

Pages